Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isao Hara

Showing results (81-90 of 361) with videos related to

Pageof 37
Sort By:
Oncology Reports|February 13, 2003
Resistance to cytotoxic chemotherapy-induced apoptosis in human prostate cancer cells is associated with intracellular clusterin expressionHideaki Miyake, Isao Hara, Sadao Kamidono, et al.
BJU International|March 16, 2006
Limited significance of routine excretory urography in the follow-up of patients with superficial bladder cancer after transurethral resectionHideaki Miyake, Isao Hara, Kazuki Yamanaka, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 22, 2005
Is a limited lymphadenectomy targeting obturator nodes alone an adequate procedure for Japanese men undergoing radical prostatectomy?Hideaki Miyake, Iori Sakai, Ken-Ichi Harada, et al.
Neoplasia (New York, N.Y.)|April 2, 2005
Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer modelHideaki Miyake, Kazuki Yamanaka, Mototsugu Muramaki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 26, 2004
Increased detection of clinically significant prostate cancer by additional sampling from the anterior lateral horns of the peripheral zone in combination with the standard sextant biopsyHideaki Miyake, Iori Sakai, Ken-ichi Harada, et al.
International Journal of Clinical Oncology|February 25, 2005
Clinicopathological features of prostate cancer in Japanese men diagnosed on repeat transrectal ultrasound-guided biopsyHideaki Miyake, Iori Sakai, Ken-ichi Harada, et al.
Molecular Cancer Therapeutics|February 17, 2005
Synergistic antitumor effect of combined use of adenoviral-mediated p53 gene transfer and antisense oligodeoxynucleotide targeting clusterin gene in an androgen-independent human prostate cancer modelKazuki Yamanaka, Martin E Gleave, Isao Hara, et al.
The Journal of Urology|April 17, 2002
Introducing the clusterin gene into human renal cell carcinoma cells enhances their metastatic potentialHideaki Miyake, Martin E Gleave, Soichi Arakawa, et al.
BJU International|August 18, 2005
A comparison of the biological features between prostate cancers arising in the transition and peripheral zonesIori Sakai, Ken-Ichi Harada, Isao Hara, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 15, 2005
Intussusception of the bladder neck does not promote early restoration to urinary continence after non-nerve-sparing radical retropubic prostatectomyIori Sakai, Ken-Ichi Harada, Isao Hara, et al.
Pageof 37

Showing results (81-90 of 361) with videos related to

Sort By:
Pageof 37
Oncology Reports|February 13, 2003
Resistance to cytotoxic chemotherapy-induced apoptosis in human prostate cancer cells is associated with intracellular clusterin expressionHideaki Miyake, Isao Hara, Sadao Kamidono, et al.
BJU International|March 16, 2006
Limited significance of routine excretory urography in the follow-up of patients with superficial bladder cancer after transurethral resectionHideaki Miyake, Isao Hara, Kazuki Yamanaka, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 22, 2005
Is a limited lymphadenectomy targeting obturator nodes alone an adequate procedure for Japanese men undergoing radical prostatectomy?Hideaki Miyake, Iori Sakai, Ken-Ichi Harada, et al.
Neoplasia (New York, N.Y.)|April 2, 2005
Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer modelHideaki Miyake, Kazuki Yamanaka, Mototsugu Muramaki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 26, 2004
Increased detection of clinically significant prostate cancer by additional sampling from the anterior lateral horns of the peripheral zone in combination with the standard sextant biopsyHideaki Miyake, Iori Sakai, Ken-ichi Harada, et al.
International Journal of Clinical Oncology|February 25, 2005
Clinicopathological features of prostate cancer in Japanese men diagnosed on repeat transrectal ultrasound-guided biopsyHideaki Miyake, Iori Sakai, Ken-ichi Harada, et al.
Molecular Cancer Therapeutics|February 17, 2005
Synergistic antitumor effect of combined use of adenoviral-mediated p53 gene transfer and antisense oligodeoxynucleotide targeting clusterin gene in an androgen-independent human prostate cancer modelKazuki Yamanaka, Martin E Gleave, Isao Hara, et al.
The Journal of Urology|April 17, 2002
Introducing the clusterin gene into human renal cell carcinoma cells enhances their metastatic potentialHideaki Miyake, Martin E Gleave, Soichi Arakawa, et al.
BJU International|August 18, 2005
A comparison of the biological features between prostate cancers arising in the transition and peripheral zonesIori Sakai, Ken-Ichi Harada, Isao Hara, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 15, 2005
Intussusception of the bladder neck does not promote early restoration to urinary continence after non-nerve-sparing radical retropubic prostatectomyIori Sakai, Ken-Ichi Harada, Isao Hara, et al.
Pageof 37